journal article Open Access Mar 01, 2026

Barriers and facilitators to implementing a shared decision-making tool for anticoagulant-related drug–drug interactions: a qualitative study across three academic medical centres in the USA

BMJ Open Vol. 16 No. 3 pp. e110074 · BMJ
View at Publisher Save 10.1136/bmjopen-2025-110074
Abstract
Objectives
To identify barriers and facilitators to implementing an electronic shared decision-making tool for managing anticoagulant-related drug-drug interactions that affect bleeding risk in routine clinical care.


Design
Preimplementation qualitative study using semistructured interviews.


Setting
Three academic medical centres in the southeastern and western USA. Interviews were conducted between 27 March and 25 September 2024.


Participants
36 participants, including 19 clinicians involved in prescribing or managing anticoagulants and seventeen patients prescribed anticoagulants, were recruited using purposive and convenience sampling.


Results
Participants identified multiple barriers and facilitators to tool implementation. Common barriers included limited visit time, challenges integrating the tool into existing workflows, role and scope-of-practice constraints, and variation in patient digital literacy. Facilitators included clear visualisation of bleeding risk, access to supporting evidence, familiar interface design and perceived potential to support patient engagement and shared decision-making. Several determinants functioned as both barriers and facilitators, depending on clinical context and user role.


Conclusions
This preimplementation qualitative study identified context-specific determinants that influence the adoption of an electronic shared decision-making tool for anticoagulant-related drug–drug interactions. Findings highlight the importance of early attention to workflow integration, role alignment and usability to support uptake in routine care. Addressing these factors during design and implementation may inform strategies to support adoption and future evaluation in real-world clinical settings.
Topics

No keywords indexed for this article. Browse by subject →

References
35
[2]
Chen "Barriers and enablers to implementing and using clinical decision support systems for chronic diseases: a qualitative systematic review and meta-aggregation" Implement Sci Commun (2022) 10.1186/s43058-022-00326-x
[3]
Newton "A systematic review of clinicians’ acceptance and use of clinical decision support systems over time" NPJ Digit Med (2025) 10.1038/s41746-025-01662-7
[4]
Conceptualizing outcomes for use with the Consolidated Framework for Implementation Research (CFIR): the CFIR Outcomes Addendum

Laura J. Damschroder, Caitlin M. Reardon, Marilla A. Opra Widerquist et al.

Implementation Science 2022 10.1186/s13012-021-01181-5
[5]
Alley "The relative value of Pre-Implementation stages for successful implementation of evidence-informed programs" Implement Sci (2023) 10.1186/s13012-023-01285-0
[6]
Shared Decision Making: A Model for Clinical Practice

Glyn Elwyn, Dominick Frosch, Richard Thomson et al.

Journal of General Internal Medicine 10.1007/s11606-012-2077-6
[7]
Elwyn "A three-talk model for shared decision making: multistage consultation process" BMJ (2017) 10.1136/bmj.j4891
[8]
Stacey "Decision aids for people facing health treatment or screening decisions" Cochrane Database Syst Rev (2024)
[9]
Salwei "The decision aid is the easy part: workflow challenges of shared decision making in cancer care" J Natl Cancer Inst (2023) 10.1093/jnci/djad133
[10]
Sepucha "Informed, Patient-Centered Decisions Associated with Better Health Outcomes in Orthopedics: Prospective Cohort Study" Med Decis Making (2018) 10.1177/0272989x18801308
[11]
Troy "National Trends in Use of and Spending on Oral Anticoagulants Among US Medicare Beneficiaries From 2011 to 2019" JAMA Health Forum (2021) 10.1001/jamahealthforum.2021.1693
[12]
Glise Sandblad "Excess risk of bleeding in patients with venous thromboembolism on direct oral anticoagulants during initial and extended treatment versus population controls" J Intern Med (2025) 10.1111/joim.20067
[16]
Rahman "Concomitant Use of Selective Serotonin Reuptake Inhibitors With Oral Anticoagulants and Risk of Major Bleeding" JAMA Netw Open (2024) 10.1001/jamanetworkopen.2024.3208
[18]
Ardeshna "Outcomes of Oral Anticoagulation with Concomitant NSAID Use: A Registry Based Cohort Study" Am J Med (2025) 10.1016/j.amjmed.2025.06.034
[19]
Grymonprez "Pharmacodynamic Drug-Drug Interactions and Bleeding Outcomes in Patients with Atrial Fibrillation Using Non-Vitamin K Antagonist Oral Anticoagulants: a Nationwide Cohort Study" Cardiovasc Drugs Ther (2025) 10.1007/s10557-023-07521-5
[20]
Petersen "Bleeding risk using non-steroidal anti-inflammatory drugs with anticoagulants after venous thromboembolism: a nationwide Danish study" Eur Heart J (2025) 10.1093/eurheartj/ehae736
[25]
Reese "A Shared Decision-making Tool for Drug Interactions Between Warfarin and Nonsteroidal Anti-inflammatory Drugs: Design and Usability Study" JMIR Hum Factors (2021) 10.2196/28618
[26]
Gomez Lumbreras "Shared Decision-Making for Drug-Drug Interactions: Formative Evaluation of an Anticoagulant Drug Interaction" JMIR Form Res (2022) 10.2196/40018
[27]
Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups

A. Tong, P. Sainsbury, J. Craig

International Journal for Quality in Health Care 10.1093/intqhc/mzm042
[28]
Ancker "Guidance for publishing qualitative research in informatics" J Am Med Inform Assoc (2021) 10.1093/jamia/ocab195
[29]
The updated Consolidated Framework for Implementation Research based on user feedback

Laura J. Damschroder, Caitlin M. Reardon, Marilla A. Opra Widerquist et al.

Implementation Science 2022 10.1186/s13012-022-01245-0
[30]
Ayele "Study protocol: improving the transition of care from a non-network hospital back to the patient’s medical home" BMC Health Serv Res (2017) 10.1186/s12913-017-2048-z
[32]
A simple method to assess and report thematic saturation in qualitative research

Greg Guest, Emily Namey, Mario Chen

PLoS ONE 2020 10.1371/journal.pone.0232076
[33]
Hemmler "Beyond a coefficient: an interactive process for achieving inter-rater consistency in qualitative coding" Qual Res (2022) 10.1177/1468794120976072
[34]
Knowledge is not power for patients: A systematic review and thematic synthesis of patient-reported barriers and facilitators to shared decision making

Natalie Joseph-Williams, Glyn Elwyn, Adrian Edwards

Patient Education and Counseling 10.1016/j.pec.2013.10.031
Metrics
0
Citations
35
References
Details
Published
Mar 01, 2026
Vol/Issue
16(3)
Pages
e110074
License
View
Authors
Funding
Agency for Healthcare Research and Quality Award: R18 HS029300-01
Cite This Article
Robert A Becker, Kemberlee Bonnet, Mauli V Shah, et al. (2026). Barriers and facilitators to implementing a shared decision-making tool for anticoagulant-related drug–drug interactions: a qualitative study across three academic medical centres in the USA. BMJ Open, 16(3), e110074. https://doi.org/10.1136/bmjopen-2025-110074